No Data
No Data
Alzamend Neuro Unveils Updated Investor Presentation Outlook
Express News | Alzamend Neuro Inc: Expects to Use Proceeds to Further Its Clinical Trials and Working Capital Purposes
Express News | Alzamend Neuro Inc: Investor Had Agreed to Purchase up to $25 Mln of Preferred Shares
Express News | Alzamend Neuro Announces Initial Closing of Private Placement
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAethlon Medical (NASDAQ:AEMD) stock moved upwards by 129.0% to $2.7 during Friday's pre-market session. The company's market cap stands at $7.1 million. Novavax (NASDAQ:NVAX) shares rose 119.23
Alzamend Neuro Secures Strategic $25M Investment Deal